论文信息 - Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae. - 字舞流文

Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.

E. Pérez-Nadales | E. Seminari | O. Manuel | P. Martín-Dávila | P. Grossi | E. Cordero | R. Avery | J. Rodríguez-Baño | P. Muñoz | B. Pilmis | J. Lepe | L. Martínez-Martínez | C. van Delden | M. Falcone | J. Aguado | E. Roilides | J. Torre-Cisneros | B. Tan | M. Rana | E. Abdala | M. Freire | M. Paul | F. Gunseren | F. Raffaelli | M. Bodro | M. Fariñas | J. Fortún | H. Arslan | M. Rizzi | J. Carratalá | W. Clemente | L. Pierrotti | D. Ostrander | M. Tumbarello | E. Lease | A. Mularoni | B. Loeches | E. Kazak | G. Russelli | Z. Tufan | W. Lowman | S. Steinke | F. Soldani | B. Eriksson | Laurent Dewispelaere | M. David | G. Tiseo | B. Gutiérrez-Gutiérrez | J. Castón | J. Coussement | I. Oriol | E. Merino de Lucas | R. Rodríguez-Álvarez | E. Gervasi | J. A. Lepe | Á. Pascual | J. A. Marín-Sanz | Alejandra M. Natera | Mario Fernández-Ruiz | Víctor Gálvez-Soto | T. M. Varejão Strabelli | Iyer Ranganathan N

[1] H. Ding,et al. Efficacy of Ceftazidime-Avibactam in the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection After Kidney Transplantation , 2021, Infection and drug resistance.

[2] Jie Gu,et al. Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae: Ceftazidime-avibactam against CR-KP infections. , 2021, Journal of global antimicrobial resistance.

[3] H. Bai,et al. Allograft hemorrhage as a manifestation of carbapenem-resistant Klebsiella pneumonia infection in kidney transplant recipients , 2020, Medicine.

[4] K. Kazmierczak,et al. In vitro activity of ceftazidime/avibactam against isolates of carbapenem-non-susceptible Enterobacteriaceae collected during the INFORM global surveillance programme (2015–17) , 2019, The Journal of antimicrobial chemotherapy.

[5] S. Signoriello,et al. EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS. , 2019, International journal of antimicrobial agents.

[6] Roopali Sharma,et al. Carbapenem‐resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime‐avibactam , 2018, Transplant infectious disease : an official journal of the Transplantation Society.

[7] B. Kreiswirth,et al. Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections , 2018, Antimicrobial Agents and Chemotherapy.

[8] J. Rodríguez-Baño,et al. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae , 2018, Clinical Microbiology Reviews.

[9] R. Bonomo,et al. Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10] V. Yu,et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. , 1989, The American journal of medicine.

[11] A. Oliver,et al. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. , 2018, Transplantation reviews.

[12] A. Fernández-Rodríguez,et al. Ceftazidime-avibactam in urinary tract infections due to carbapenemase-producing Klebsiella in kidney transplantation. , 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[13] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.